ライフサイエンスコーパス: matrix metalloproteinase 7

1 n to myeloperoxidase-dependent activation of matrix metalloproteinase 7.

2 or repression of Kaiso target genes, such as matrix metalloproteinase-7.

3 tive precursors (pro-Crps) by the convertase matrix metalloproteinase-7.

4 vascular smooth muscle cells layers and were matrix metalloproteinase-7 and -9 immunopositive.

5 tor [TNF]), TNF-alpha-converting enzyme, and matrix metalloproteinase-7 and -9) were assessed on HCLE

6 splayed similar CCL expression and suggested matrix metalloproteinase-7 and MMP9 as possible extracel

7 Matrix metalloproteinase-7 and neutrophil elastase induc

8 s by stimulating expression and secretion of matrix metalloproteinases 7 and 9 (MMP7/9), by which MMP

9 Two proteases that process OPN (thrombin and matrix metalloproteinase 7) and cleaved OPN were increas

10 h as Bcl-2 (B-cell lymphoma 2), c-Myc, MMP7 (matrix metalloproteinase-7), and cyclin D1in vitro and i

11 ls of vascular endothelial growth factor and matrix metalloproteinase 7, and increased invasive behav

12 ing the SARS-CoV-2 main protease, caspase-3, matrix metalloproteinase-7, and cathepsin B-simply by al

13 four serum biomarkers (surfactant protein D, matrix metalloproteinase 7, CA19-9, and CA-125) that wer

14 It was found that matrix metalloproteinase-7-deficient (MMP-7(-/-)) mice,

15 of the matrix metalloproteinase matrilysin (matrix metalloproteinase-7) in the mouse mammary gland p

16 Matrilysin (matrix metalloproteinase-7) is expressed by mucosal epit

17 Matrilysin-1 (also called matrix metalloproteinase-7) is expressed in injured lung

18 Matrilysin (matrix metalloproteinase-7) is highly expressed in lungs

19 n (CD44HSPG) recruits proteolytically active matrix metalloproteinase 7 (matrilysin, MMP-7) and hepar

20 eolytic activation of inactive precursors by matrix metalloproteinase-7 (matrilysin, EC, MMP-7(a)).

21 s associated with epithelial barrier repair (matrix metalloproteinase 7, matrix metalloproteinase 3,

22 s, termed cryptdins (Crps), are activated by matrix metalloproteinase-7-mediated proteolysis of inact

23 duced seizures, the proNGF processing enzyme matrix metalloproteinase 7 (MMP-7) and its inhibitor TIM

24 Proteomic analysis of uEVs identified matrix metalloproteinase 7 (MMP-7) as a biomarker predic

25 with survival, accounting for the effect of matrix metalloproteinase 7 (MMP-7) blood concentration a

26 vitro acinar transdifferentiation depends on matrix metalloproteinase 7 (MMP-7), a proteinase express

27 RATIONALE: Matrix metalloproteinase-7 (MMP-7) has been implicated i

28 High levels of serum matrix metalloproteinase-7 (MMP-7) have been linked to b

29 Matrix metalloproteinase-7 (MMP-7) is a proteolytic enzy

30 Matrix metalloproteinase-7 (MMP-7) is a small secreted p

31 Here we show that matrix metalloproteinase-7 (MMP-7) is expressed not only

32 converted to bactericidal CRS4C-1 peptide by matrix metalloproteinase-7 (MMP-7) proteolysis of the pr

33 ttaching the consensus peptide substrate for matrix metalloproteinase-7 (MMP-7), an enzyme that is up

34 es, beta-catenin transcriptionally regulates matrix metalloproteinase-7 (MMP-7), but the association

35 the proteolytic activation of precursors by matrix metalloproteinase-7 (MMP-7), prompting an analysi

36 nsin precursors are cleaved and activated by matrix metalloproteinase-7 (MMP-7), we determined if add

37 lung cancer cell invasion and down-regulated matrix metalloproteinase-7 (MMP-7), which promoted lung

38 cessing of cryptdin precursors (pro-Crps) by matrix metalloproteinase-7 (MMP-7).

39 onstrate that HOCl regulates the activity of matrix metalloproteinase-7 (MMP-7, matrilysin) in vitro,

40 ng sites (4xKBS) and the known Kaiso target, Matrix metalloproteinase-7 (MMP-7/Matrilysin).

41 ires proteolytic activation of precursors by matrix metalloproteinase-7 (MMP-7; matrilysin).

42 C4-Fc (truncated N-cadherin), or deletion of matrix-metalloproteinase-7 (Mmp-7) reduced VSMC apoptosi

43 riptional responses dependent on matrilysin (matrix metalloproteinase 7 [MMP-7]) and stromelysin-2 (M

44 We previously identified matrix metalloproteinase 7 (MMP7) as a serum biomarker o

45 We identified matrix metalloproteinase 7 (MMP7) as an enzyme with a te

46 adenocarcinoma with a concurrent increase of matrix metalloproteinase 7 (MMP7) expression in mouse pr

47 To delineate the role of matrix metalloproteinase 7 (MMP7) in mammary tumorigenes

48 In addition, loss of matrix metalloproteinase 7 (MMP7) increases mucosal infl

49 Kidney protein and RNA levels of matrix metalloproteinase 7 (MMP7) strongly correlated wi

50 interleukin 25, we show here that epithelial matrix metalloproteinase 7 (MMP7) was expressed during a

51 Expression of matrix metalloproteinase 7 (MMP7), an AP-1 target, was a

52 up-regulation of the NF-kappaB target gene, matrix metalloproteinase 7 (MMP7).

53 We show that elevated levels of matrix metalloproteinase-7 (MMP7) and a disintegrin and

54 In mice, matrix metalloproteinase-7 (MMP7) converts inactive pro-

55 in compositional analysis with LC-MS/MS, and matrix metalloproteinase-7 (MMP7) were identified as a p

56 fic PCR array assays revealed that WNT5A and matrix metalloproteinase-7 (MMP7) were upregulated by FO

57 lationship between the expression of FXR and matrix metalloproteinase-7 (MMP7), a collagenase and sig

58 A biomarker signature composed of matrix metalloproteinase 7, pulmonary and activation-reg

59 rtantly, a combinatorial signature including matrix metalloproteinase 7, pulmonary and activation-reg

60 ), angiopoietin-2 (related to angiogenesis), matrix metalloproteinase-7 (related to extracellular mat

61 , saliva Vascular-endothelium-growth-factor, Matrix-metalloproteinase-7, serum Epithelial-neutrophil-

62 4, killer immunoglobulin-like receptors, and matrix metalloproteinase-7 were also found to be associa